Bausch + Lomb acquires ISTA Pharmaceuticals (ISTA) for $500M, or $9.10 per share in cash. The...
Bausch + Lomb acquires ISTA Pharmaceuticals (ISTA) for $500M, or $9.10 per share in cash. The transaction is expected to strengthen Bausch + Lomb's overall product pipeline and is expected to close in 2Q12.
From other sites
at MarketRealist.com (Fri, 11:06AM)
at Zacks.com (Mar 25, 2015)
at Zacks.com (Mar 24, 2015)
at MarketRealist.com (Mar 23, 2015)
at Zacks.com (Mar 23, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs